Loading news...
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily injections GALWAY, Ireland, Jan. 12, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its MiniMed Go™ app. The MiniMed Go™ Smart Multiple Daily Injection (MDI) system seamlessly integrates the InPen™ smart insulin pen with the Instinct sensor made by Abbott — all connected through the MiniMed Go™ app.
Vertex and Medtronic could see strong momentum this year, while Pfizer is still facing challenges. Regardless of what happens in 2026, though, Vertex and Medtronic have attractive prospects.
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?
Cerity Partners LLC grew its position in shares of Medtronic PLC (NYSE: MDT) by 15.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 701,904 shares of the medical technology company's stock after purchasing an additional 92,968 shares during the
On Tuesday, William Blair upgraded Medtronic Plc (NYSE: MDT), citing several new and ramping launches.
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.
LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.
WestEnd Advisors LLC lowered its position in shares of Medtronic PLC (NYSE: MDT) by 1.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 464,734 shares of the medical technology company's stock after selling 8,573 shares during the quarter. Medtronic makes
Asset Management One Co. Ltd. raised its position in Medtronic PLC (NYSE: MDT) by 2.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 589,186 shares of the medical technology company's stock after acquiring an additional 13,594 shares during
Capital Advisors Inc. OK raised its holdings in Medtronic PLC (NYSE: MDT) by 24.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 590,228 shares of the medical technology company's stock after purchasing an additional 117,590 shares during the quarter. Capital
Visa has a resilient business, a solid competitive edge, and attractive avenues for growth. Medtronic is performing well, and new product launches are providing a potentially long-lasting tailwind.
First Pacific Financial grew its holdings in shares of Medtronic PLC (NYSE: MDT) by 23.4% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 46,817 shares of the medical technology company's stock after buying an additional 8,870 shares during the period. Medtronic accounts for
Ascent Group LLC trimmed its holdings in shares of Medtronic PLC (NYSE: MDT) by 55.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,137 shares of the medical technology company's stock after selling 21,164 shares during the quarter. Ascent Group
Calamos Advisors LLC increased its holdings in shares of Medtronic PLC (NYSE: MDT) by 27.9% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 538,018 shares of the medical technology company's stock after purchasing an additional 117,358 shares during the quarter. Calamos
Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device maker that's nearing Dividend King status.
Diversified Trust Co grew its stake in shares of Medtronic PLC (NYSE: MDT) by 32.8% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 96,875 shares of the medical technology company's stock after acquiring an additional 23,906 shares
Continuum Advisory LLC lifted its stake in Medtronic PLC (NYSE: MDT) by 56.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 24,974 shares of the medical technology company's stock after purchasing an additional 9,048 shares during the quarter. Continuum Advisory LLC's holdings